搜尋結果
Lilly Raises 2024 Guidance as Zepbound Flies Off Shelves
Bloomberg· 5 日前... after it raised its annual guidance on soaring demand for its blockbuster weight ... ...
Jim Cramer's top 10 things to watch in the stock market Tuesday
CNBC· 5 日前The Dow is on pace for a 3% loss, while the S&P 500 and Nasdaq are each looking at 2% declines. ...
Can Ozempic Maker Novo Nordisk Keep Up Its Momentum? - What’s News - WSJ Podcasts
The Wall Street Journal· 3 日前Emily Field: This morning, Novo talked about a quadrupling of new patients starting Wegovy on a weekly basis in the United ...
61-year-old HK actor Chin Siu-ho continues to attract young women despite drastic weight loss ...
Dimsum Daily· 4 日前1st May 2024 – (Hong Kong) Chin Siu-ho, widely known for his youthful looks during his prime, gained popularity through ...
Wegovy Sales More Than Double as Demand Soars
The Wall Street Journal· 3 日前Novo Nordisk raised its full-year guidance to reflect better pricing in the U.S. and as global ...
Bloomberg Talks: Novo Nordisk CEO Lars Fruergaard Jorgensen - Bloomberg
Bloomberg· 3 日前Curating today’s top interviews from around Bloomberg News. Hear conversations with the biggest ...
Forbes Daily: Why ‘Bitcoin Jesus’ Could Be Extradited To The U.S.
Forbes· 3 日前What if your pharmacist could prescribe your medications? In select cases at pharmacy giants ...
Novo Boosts Wegovy Shipments as Lilly Rivalry Pressures Prices
Bloomberg· 3 日前Have a confidential tip for our reporters? Novo Nordisk A/S is shipping more introductory doses ...
Stocks making the biggest moves midday: Eli Lilly, 3M, PayPal, Tesla and more
CNBC· 5 日前These were some of the stocks making the largest moves in trading on Tuesday.
Denmark to restrict Ozempic, other GLP-1 drugs, to treat type 2 diabetes
Reuters· 4 日前In 2023, 50% of new patients suffering from type 2 diabetes began treatment with a reimbursed ...